Trastuzumab as single agent therapy for HER2-positive metastatic breast cancer

Priya Rastogi, Nancy E. Davidson

Research output: Contribution to journalEditorialpeer-review

Fingerprint

Dive into the research topics of 'Trastuzumab as single agent therapy for HER2-positive metastatic breast cancer'. Together they form a unique fingerprint.